Siegfried Holding Ltd (SW:SFZN) — Market Cap & Net Worth
Market Cap & Net Worth: Siegfried Holding Ltd (SFZN)
Siegfried Holding Ltd (SW:SFZN) has a market capitalization of $3.71 Billion (CHF2.94 Billion) as of May 2, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #4334 globally and #65 in its home market, demonstrating a -2.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Siegfried Holding Ltd's stock price CHF78.70 by its total outstanding shares 43768270 (43.77 Million). Analyse SFZN cash flow metrics to see how efficiently the company converts income to cash.
Siegfried Holding Ltd Market Cap History: 2015 to 2026
Siegfried Holding Ltd's market capitalization history from 2015 to 2026. Data shows change from $10.25 Billion to $4.35 Billion (-7.13% CAGR).
Siegfried Holding Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Siegfried Holding Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
42.15x
Siegfried Holding Ltd's market cap is 42.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
340.87x
Siegfried Holding Ltd's market cap is 340.87 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.25 Billion | $480.57 Million | $39.10 Million | 21.33x | 262.20x |
| 2016 | $11.27 Billion | $717.73 Million | $27.91 Million | 15.70x | 403.73x |
| 2017 | $17.26 Billion | $750.47 Million | $39.73 Million | 23.00x | 434.47x |
| 2018 | $18.03 Billion | $794.30 Million | $56.31 Million | 22.70x | 320.16x |
| 2019 | $25.34 Billion | $833.51 Million | $53.15 Million | 30.40x | 476.82x |
| 2020 | $35.43 Billion | $845.06 Million | $60.87 Million | 41.93x | 582.11x |
| 2021 | $48.54 Billion | $1.10 Billion | $95.60 Million | 44.03x | 507.73x |
| 2022 | $33.65 Billion | $1.23 Billion | $156.49 Million | 27.37x | 215.04x |
| 2023 | $47.37 Billion | $1.27 Billion | $112.77 Million | 37.25x | 420.02x |
| 2024 | $54.56 Billion | $1.29 Billion | $160.06 Million | 42.15x | 340.87x |
Competitor Companies of SFZN by Market Capitalization
Companies near Siegfried Holding Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Siegfried Holding Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Siegfried Holding Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Siegfried Holding Ltd's market cap moved from $10.25 Billion to $ 4.35 Billion, with a yearly change of -7.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF4.35 Billion | +5.50% |
| 2025 | CHF4.13 Billion | -92.43% |
| 2024 | CHF54.56 Billion | +15.19% |
| 2023 | CHF47.37 Billion | +40.76% |
| 2022 | CHF33.65 Billion | -30.67% |
| 2021 | CHF48.54 Billion | +36.99% |
| 2020 | CHF35.43 Billion | +39.81% |
| 2019 | CHF25.34 Billion | +40.56% |
| 2018 | CHF18.03 Billion | +4.44% |
| 2017 | CHF17.26 Billion | +53.22% |
| 2016 | CHF11.27 Billion | +9.89% |
| 2015 | CHF10.25 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Siegfried Holding Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.71 Billion USD |
| MoneyControl | $3.71 Billion USD |
| MarketWatch | $3.71 Billion USD |
| marketcap.company | $3.71 Billion USD |
| Reuters | $3.71 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Siegfried Holding Ltd
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pa… Read more